Dirk Beher (Chief Executive Officer FundaMental Pharma)
Chief Executive Officer and executive member of the board of directors at FundaMental Pharma
ArticleWhy NMDA receptor modulation remains central to next-generation depression therapies
A key player in brain communication and mood regulation, the pharmaceutical industry views the NMDAR as the central pillar for next-generation therapies for depression. Dirk Beher from FundaMental Pharma reveals new strategies for targeting this important receptor.